D. E. Shaw & Co., Inc. Ptc Therapeutics, Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $46,260 - $86,184	-1,800 Reduced 3.23%	54,000 $1.82 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $974,268 - $1.82 Million	55,800 New	55,800 $1.51 Million

222

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.09B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.